Works by Reardon, David

Results: 262

The emerging role of anti-angiogenic therapy for malignant glioma.

Published in:

2008

By:

Reardon, David;
Desjardins, Annick;
Rich, Jeremy;
Vredenburgh, James;
Reardon, David A;
Rich, Jeremy N;
Vredenburgh, James J

Publication type:

journal article

Survival and prognostic factors in surgically treated brain metastases.

Published in:

Journal of Neuro-Oncology, 2019, v. 143, n. 2, p. 359, doi. 10.1007/s11060-019-03171-6

By:

Kavouridis, Vasileios K.;
Harary, Maya;
Hulsbergen, Alexander F. C.;
Lo, Yu T.;
Reardon, David A.;
Aizer, Ayal A.;
Iorgulescu, J. Bryan;
Smith, Timothy R.

Publication type:

Article

Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?

Published in:

Journal of Neuro-Oncology, 2018, v. 138, n. 1, p. 163, doi. 10.1007/s11060-018-2786-8

By:

Happold, Caroline;
Gorlia, Thierry;
Nabors, L. Burt;
Erridge, Sara C.;
Reardon, David A.;
Hicking, Christine;
Picard, Martin;
Stupp, Roger;
Weller, Michael;
For the EORTC Brain Tumor Group and on behalf of the CENTRIC and CORE Clinical Trial Groups

Publication type:

Article

Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas.

Published in:

Journal of Neuro-Oncology, 2018, v. 137, n. 2, p. 349, doi. 10.1007/s11060-017-2724-1

By:

Peters, Katherine B.;
Lipp, Eric S.;
Miller, Elizabeth;
Herndon II, James E.;
McSherry, Frances;
Desjardins, Annick;
Reardon, David A.;
Friedman, Henry S.

Publication type:

Article

Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.

Published in:

Journal of Neuro-Oncology, 2017, v. 135, n. 3, p. 581, doi. 10.1007/s11060-017-2611-9

By:

Arvold, Nils;
Shi, Diana;
Aizer, Ayal;
Norden, Andrew;
Reardon, David;
Lee, Eudocia;
Nayak, Lakshmi;
Dunn, Ian;
Golby, Alexandra;
Johnson, Mark;
Claus, Elizabeth;
Chiocca, E.;
Ligon, Keith;
Wen, Patrick;
Alexander, Brian

Publication type:

Article

Brachytherapy in the treatment of recurrent aggressive falcine meningiomas.

Published in:

Journal of Neuro-Oncology, 2015, v. 124, n. 3, p. 515, doi. 10.1007/s11060-015-1873-3

By:

Abou Al-Shaar, Hussam;
Almefty, Kaith;
Abolfotoh, Mohammad;
Arvold, Nils;
Devlin, Phillip;
Reardon, David;
Loeffler, Jay;
Al-Mefty, Ossama

Publication type:

Article

Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation.

Published in:

Journal of Neuro-Oncology, 2015, v. 124, n. 1, p. 137, doi. 10.1007/s11060-015-1820-3

By:

Rahman, Rifaquat;
Catalano, Paul;
Reardon, David;
Norden, Andrew;
Wen, Patrick;
Lee, Eudocia;
Nayak, Lakshmi;
Beroukhim, Rameen;
Dunn, Ian;
Golby, Alexandra;
Johnson, Mark;
Chiocca, E.;
Claus, Elizabeth;
Alexander, Brian;
Arvold, Nils

Publication type:

Article

Re-defining response and treatment effects for neuro-oncology immunotherapy clinical trials.

Published in:

Journal of Neuro-Oncology, 2015, v. 123, n. 3, p. 339, doi. 10.1007/s11060-015-1748-7

By:

Reardon, David;
Okada, Hideho

Publication type:

Article

Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 297, doi. 10.1007/s11060-014-1631-y

By:

Norden, Andrew;
Schiff, David;
Ahluwalia, Manmeet;
Lesser, Glenn;
Nayak, Lakshmi;
Lee, Eudocia;
Rinne, Mikael;
Muzikansky, Alona;
Dietrich, Jorg;
Purow, Benjamin;
Doherty, Lisa;
LaFrankie, Debra;
Pulverenti, Julee;
Rifenburg, Jennifer;
Ruland, Sandra;
Smith, Katrina;
Gaffey, Sarah;
McCluskey, Christine;
Ligon, Keith;
Reardon, David

Publication type:

Article

Histogram analysis of apparent diffusion coefficient within enhancing and nonenhancing tumor volumes in recurrent glioblastoma patients treated with bevacizumab.

Published in:

Journal of Neuro-Oncology, 2014, v. 119, n. 1, p. 149, doi. 10.1007/s11060-014-1464-8

By:

Rahman, Rifaquat;
Hamdan, Alhafidz;
Zweifler, Rebecca;
Jiang, Han;
Norden, Andrew;
Reardon, David;
Mukundan, Srinivasan;
Wen, Patrick;
Huang, Raymond

Publication type:

Article

O-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma.

Published in:

Journal of Neuro-Oncology, 2013, v. 114, n. 1, p. 135, doi. 10.1007/s11060-013-1162-y

By:

Jiang, Xiaoyin;
Reardon, David;
Desjardins, Annick;
Vredenburgh, James;
Quinn, Jennifer;
Austin, Alan;
Herndon, James;
McLendon, Roger;
Friedman, Henry

Publication type:

Article

PCV for anaplastic oligodendrogliomas: back to the future or a step backwards?

Published in:

Journal of Neuro-Oncology, 2013, v. 113, n. 1, p. 143, doi. 10.1007/s11060-013-1100-z

By:

Villano, J.;
Wen, Patrick;
Lee, Eudocia;
Nayak, Lakshmi;
Reardon, David;
Rosenfeld, Myrna

Publication type:

Article

Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model.

Published in:

Journal of Neuro-Oncology, 2013, v. 111, n. 2, p. 97, doi. 10.1007/s11060-012-0995-0

By:

Keir, Stephen;
Friedman, Henry;
Reardon, David;
Bigner, Darell;
Gray, Lloyd

Publication type:

Article

A dose escalation trial for the combination of erlotinib and sirolimus for recurrent malignant gliomas.

Published in:

Journal of Neuro-Oncology, 2012, v. 110, n. 2, p. 245, doi. 10.1007/s11060-012-0960-y

By:

Nghiemphu, Phioanh;
Lai, Albert;
Green, Richard;
Reardon, David;
Cloughesy, Timothy

Publication type:

Article

Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series.

Published in:

Journal of Neuro-Oncology, 2012, v. 109, n. 1, p. 63, doi. 10.1007/s11060-012-0861-0

By:

Lou, Emil;
Sumrall, Ashley;
Turner, Scott;
Peters, Katherine;
Desjardins, Annick;
Vredenburgh, James;
McLendon, Roger;
Herndon, James;
McSherry, Frances;
Norfleet, Julie;
Friedman, Henry;
Reardon, David

Publication type:

Article

Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma.

Published in:

Journal of Neuro-Oncology, 2012, v. 108, n. 3, p. 499, doi. 10.1007/s11060-012-0848-x

By:

Reardon, David;
Vredenburgh, James;
Desjardins, Annick;
Peters, Katherine;
Sathornsumetee, Sith;
Threatt, Stevie;
Sampson, John;
Herndon, James;
Coan, April;
McSherry, Frances;
Rich, Jeremy;
McLendon, Roger;
Zhang, Steven;
Friedman, Henry

Publication type:

Article

Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients.

Published in:

Journal of Neuro-Oncology, 2012, v. 107, n. 1, p. 213, doi. 10.1007/s11060-011-0740-0

By:

Reardon, David;
Herndon, James;
Peters, Katherine;
Desjardins, Annick;
Coan, April;
Lou, Emil;
Sumrall, Ashley;
Turner, Scott;
Sathornsumetee, Sith;
Rich, Jeremy;
Boulton, Susan;
Lipp, Eric;
Friedman, Henry;
Vredenburgh, James

Publication type:

Article

Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma.

Published in:

Journal of Neuro-Oncology, 2012, v. 107, n. 1, p. 155, doi. 10.1007/s11060-011-0722-2

By:

Reardon, David;
Desjardins, Annick;
Peters, Katherine;
Gururangan, Sridharan;
Sampson, John;
McLendon, Roger;
Herndon, James;
Bulusu, Anuradha;
Threatt, Stevie;
Friedman, Allan;
Vredenburgh, James;
Friedman, Henry

Publication type:

Article

Phase II study of Gleevec plus hydroxyurea (HU) in adults with progressive or recurrent meningioma.

Published in:

Journal of Neuro-Oncology, 2012, v. 106, n. 2, p. 409, doi. 10.1007/s11060-011-0687-1

By:

Reardon, David;
Norden, Andrew;
Desjardins, Annick;
Vredenburgh, James;
Herndon, James;
Coan, April;
Sampson, John;
Gururangan, Sridharan;
Peters, Katherine;
McLendon, Roger;
Norfleet, Julie;
Lipp, Eric;
Drappatz, Jan;
Wen, Patrick;
Friedman, Henry

Publication type:

Article

A phase I trial of the farnesyl transferase inhibitor, SCH 66336, with temozolomide for patients with malignant glioma.

Published in:

Journal of Neuro-Oncology, 2011, v. 105, n. 3, p. 601, doi. 10.1007/s11060-011-0627-0

By:

Desjardins, Annick;
Reardon, David;
Peters, Katherine;
Threatt, Stevie;
Coan, April;
Herndon, James;
Friedman, Allan;
Friedman, Henry;
Vredenburgh, James

Publication type:

Article

Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma.

Published in:

Journal of Neuro-Oncology, 2011, v. 105, n. 3, p. 621, doi. 10.1007/s11060-011-0631-4

By:

Reardon, David;
Vredenburgh, James;
Coan, April;
Desjardins, Annick;
Peters, Katherine;
Gururangan, Sridharan;
Sathornsumetee, Sith;
Rich, Jeremy;
Herndon, James;
Friedman, Henry

Publication type:

Article

Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy.

Published in:

Journal of Neuro-Oncology, 2011, v. 103, n. 2, p. 371, doi. 10.1007/s11060-010-0403-6

By:

Reardon, David;
Desjardins, Annick;
Peters, Katherine;
Gururangan, Sridharan;
Sampson, John;
Rich, Jeremy;
McLendon, Roger;
Herndon, James;
Marcello, Jennifer;
Threatt, Stevie;
Friedman, Allan;
Vredenburgh, James;
Friedman, Henry

Publication type:

Article

Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma.

Published in:

Journal of Neuro-Oncology, 2011, v. 101, n. 1, p. 57, doi. 10.1007/s11060-010-0217-6

By:

Reardon, David;
Vredenburgh, James;
Desjardins, Annick;
Peters, Katherine;
Gururangan, Sridharan;
Sampson, John;
Marcello, Jennifer;
Herndon, James;
McLendon, Roger;
Janney, Dorothea;
Friedman, Allan;
Bigner, Darell;
Friedman, Henry

Publication type:

Article

Ulceration of Striae distensae in high-grade glioma patients on concurrent systemic corticosteroid and bevacizumab therapy.

Published in:

2011

By:

Peters, Katherine;
Coyle, Thomas;
Vredenburgh, James;
Desjardins, Annick;
Friedman, Henry;
Reardon, David

Publication type:

Report

Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.

Published in:

Journal of Neuro-Oncology, 2010, v. 96, n. 2, p. 219, doi. 10.1007/s11060-009-9950-0

By:

Reardon, David;
Desjardins, Annick;
Vredenburgh, James;
Gururangan, Sridharan;
Friedman, Allan;
Herndon, James;
Marcello, Jennifer;
Norfleet, Julie;
McLendon, Roger;
Sampson, John;
Friedman, Henry

Publication type:

Article

Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.

Published in:

Journal of Neuro-Oncology, 2009, v. 95, n. 3, p. 393, doi. 10.1007/s11060-009-9937-x

By:

Quinn, Jennifer A.;
Xiaoyin Jiang, Sara;
Reardon, David A.;
Desjardins, Annick;
Vredenburgh, James J.;
Friedman, Allan H.;
Sampson, John H.;
McLendon, Roger E.;
Herndon, James E.;
Friedman, Henry S.

Publication type:

Article

Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients.

Published in:

Journal of Neuro-Oncology, 2009, v. 95, n. 1, p. 129, doi. 10.1007/s11060-009-9911-7

By:

Perry, Stephanie L.;
Bohlin, Cindy;
Reardon, David A.;
Desjardins, Annick;
Friedman, Allan H.;
Friedman, Henry S.;
Vredenburgh, James J.

Publication type:

Article

Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testing.

Published in:

Journal of Neuro-Oncology, 2009, v. 94, n. 1, p. 79, doi. 10.1007/s11060-009-9803-x

By:

Jones, Lee;
Cohen, Rachel-Rose;
Mabe, Stephanie;
West, Miranda;
Desjardins, Annick;
Vredenburgh, James;
Friedman, Allan;
Reardon, David;
Waner, Emily;
Friedman, Henry

Publication type:

Article

Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma.

Published in:

Neuroradiology, 2017, v. 59, n. 2, p. 135, doi. 10.1007/s00234-016-1769-8

By:

Qin, Lei;
Li, Xiang;
Stroiney, Amanda;
Qu, Jinrong;
Helgager, Jeffrey;
Reardon, David;
Young, Geoffrey

Publication type:

Article

Improved outcomes associated with maximal extent of resection for butterfly glioblastoma: insights from institutional and national data.

Published in:

Acta Neurochirurgica, 2021, v. 163, n. 7, p. 1883, doi. 10.1007/s00701-021-04844-w

By:

Boaro, Alessandro;
Kavouridis, Vasileios K.;
Siddi, Francesca;
Mezzalira, Elisabetta;
Harary, Maya;
Iorgulescu, J. Bryan;
Reardon, David A.;
Smith, Timothy R.

Publication type:

Article

The quality of the caregiving environment and child developmental outcomes associated with maternal history of abortion using the NLSY data.

Published in:

Journal of Child Psychology & Psychiatry, 2002, v. 43, n. 6, p. 743, doi. 10.1111/1469-7610.00095

By:

Coleman, Priscilla K.;
Reardon, David C.;
Cougle, Jesse

Publication type:

Article

Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma.

Published in:

Oncologist, 2018, v. 23, n. 2, p. 157, doi. 10.1634/theoncologist.2017-0501

By:

Ghiaseddin, Ashley;
Reardon, David;
Massey, Woody;
Mannerino, Alex;
Lipp, Eric S.;
Herndon II, James E.;
McSherry, Frances;
Desjardins, Annick;
Randazzo, Dina;
Friedman, Henry S.;
Peters, Katherine B.

Publication type:

Article

Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis.

Published in:

Oncologist, 2017, v. 22, n. 6, p. 709, doi. 10.1634/theoncologist.2016-0487

By:

Larkin, James;
Chmielowski, Bartosz;
Lao, Christopher D.;
Hodi, F. Stephen;
Sharfman, William;
Weber, Jeffrey;
Suijkerbuijk, Karijn P. M.;
Azevedo, Sergio;
Li, Hewei;
Reshef, Daniel;
Avila, Alexandre;
Reardon, David A.

Publication type:

Article

Higher risk of urinary tract infections in renal transplant recipients receiving pentamidine versus trimethoprim‐sulfamethoxazole (TMP‐SMX) for Pneumocystis pneumonia prophylaxis.

Published in:

Clinical Transplantation, 2020, v. 34, n. 11, p. 1, doi. 10.1111/ctr.14067

By:

Fu, Whitney;
Barahona, Maria;
Harkness, Taylor;
Cohen, Elizabeth;
Reardon, David;
Yoo, Peter S.

Publication type:

Article

Postpartum psychiatric episodes study missed effects of prior pregnancy losses.

Published in:

Acta Psychiatrica Scandinavica, 2024, v. 150, n. 5, p. 492, doi. 10.1111/acps.13652

By:

Reardon, David C.

Publication type:

Article

Lack of Pregnancy Loss History Mars Depression Study.

Published in:

Acta Psychiatrica Scandinavica, 2012, v. 126, n. 2, p. 155, doi. 10.1111/j.1600-0447.2012.01880.x

By:

Reardon, David C.

Publication type:

Article

An Update on the Role of Immunotherapy and Vaccine Strategies for Primary Brain Tumors.

Published in:

2015

By:

Neagu, Martha R;
Reardon, David A

Publication type:

journal article

Clinical Experience with α-Particle-Emitting 211At: Treatment of Recurrent Brain Tumor Patients with 211At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6.

Published in:

Journal of Nuclear Medicine, 2008, v. 49, n. 1, p. 30, doi. 10.2967/jnumed.107.046938

By:

Zalutsky, Michael R.;
Reardon, David A.;
Akabani, Gamal;
Coleman, R. Edward;
Friedman, Allan H.;
Friedman, Henry S.;
McLendon, Roger E.;
Wong, Terence Z.;
Bigner, Darell D.

Publication type:

Article

Novel Human IgG2b/Murine Chimeric Antitenascin Monoclonal Antibody Construct Radiolabeled with 131I and Administered into the Surgically Created Resection Cavity of Patients with Malignant Glioma: Phase I Trial Results.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 912

By:

Reardon, David A.;
Quinn, Jennifer A.;
Akabani, Gamal;
Coleman, R. Edward;
Friedman, Allan H.;
Friedman, Henry S.;
Herndon II, James E.;
McLendon, Roger E.;
Pegram, Charles N.;
Provenzale, James M.;
Dowell, Jeannette M.;
Rich, Jeremy N.;
Vredenburgh, James J.;
Desjardins, Annick;
Sampson, John H.;
Gururangan, Sridharan;
Wong, Terence Z.;
Badruddoja, Michael A.;
Xiao-Guang Zhao;
Bigner, Darell D.

Publication type:

Article

Dosimetry and Radiographic Analysis of 131I-Labeled Anti--Tenascin 81C6 Murine Monoclonal Antibody in Newly Diagnosed Patients with Malignant Gliomas: A Phase II Study.

Published in:

Journal of Nuclear Medicine, 2005, v. 46, n. 6, p. 1042

By:

Akabani, Gamal;
Reardon, David A.;
Coleman, R. Edward;
Wong, Terence Z.;
Metzler, Scott D.;
Bowsher, James E.;
Barboriak, Daniel P.;
Provenzale, James M.;
Greer, Kim L.;
De Long, David;
Friedman, Henry S.;
Friedman, Allan H.;
Xiao-Guang Zhao;
Pegram, Charles N.;
McLendon, Roger E.;
Bigner, Darell D.;
Zalutsky, Michael R.

Publication type:

Article

Effects of Pregnancy Loss on Subsequent Postpartum Mental Health: A Prospective Longitudinal Cohort Study.

Published in:

International Journal of Environmental Research & Public Health, 2021, v. 18, n. 4, p. 2179, doi. 10.3390/ijerph18042179

By:

Reardon, David C.;
Craver, Christopher;
Míguez Varela, M. Carmen

Publication type:

Article

Multiple Genomic Alterations Including N-myc Amplification in a Primary Large Cell Medulloblastoma.

Published in:

Pediatric Neurosurgery, 2000, v. 32, n. 4, p. 187, doi. 10.1159/000028932

By:

Reardon, David A.;
Jenkins, Jesse J.;
Sublett, Jack E.;
Burger, Peter C.;
Kun, Larry E.

Publication type:

Article

Malignant Evolution of Choroid Plexus Papilloma.

Published in:

Pediatric Neurosurgery, 1999, v. 31, n. 3, p. 127, doi. 10.1159/000028847

By:

Chow, Edward;
Jenkins, Jesse J.;
Burger, Peter C.;
Reardon, David A.;
Langston, James W.;
Sanford, Robert A.;
Heideman, Richard L.;
Kun, Larry E.;
Merchant, Thomas E.

Publication type:

Article

High-Grade Pediatric Spinal Cord Tumors.

Published in:

Pediatric Neurosurgery, 1999, v. 30, n. 1, p. 1, doi. 10.1159/000028751

By:

Merchant, Thomas E.;
Nguyen, Duyen;
Thompson, Stephen J.;
Reardon, David A.;
Kun, Larry E.;
Sanford, Robert A.

Publication type:

Article

Bithalamic Involvement Predicts Poor Outcome among Children with Thalamic Glial Tumors.

Published in:

Pediatric Neurosurgery, 1998, v. 29, n. 1, p. 29, doi. 10.1159/000028681

By:

Reardon, David A.;
Gajjar, Amar;
Sanford, Robert A.;
Heideman, Richard L.;
Walter, Andrew W.;
Thompson, Stephen J.;
Merchant, Thomas E.;
Hao Li;
Jenkins, Jesse J.;
Langston, James;
Boyett, James M.;
Kun, Larry E.

Publication type:

Article

Cancer: The nuances of therapy.

Published in:

Nature, 2009, v. 458, n. 7236, p. 290, doi. 10.1038/458290a

By:

Ellis, Lee M.;
Reardon, David A.

Publication type:

Article

Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma.

Published in:

Oncologist, 2015, v. 20, n. 7, p. 727, doi. 10.1634/theoncologist.2015-0135

By:

Peters, Katherine B.;
Lou, Emil;
Desjardins, Annick;
Reardon, David A.;
Lipp, Eric S.;
Miller, Elizabeth;
Herndon, James E.;
McSherry, Frances;
Friedman, Henry S.;
Vredenburgh, James J.

Publication type:

Article

Analysis of Early Hypertension and Clinical Outcome With Bevacizumab: Results From Seven Phase III Studies.

Published in:

Oncologist, 2013, v. 18, n. 3, p. 273, doi. 10.1634/theoncologist.2012-0339

By:

Hurwitz, Herbert I.;
Douglas, Pamela S.;
Middleton, John P.;
Sledge, George W.;
Johnson, David H.;
Reardon, David A.;
Chen, Dafeng;
Rosen, Oliver

Publication type:

Article

Changes in Functional Performance Measures in Adults Undergoing Chemoradiation for Primary Malignant Glioma: A Feasibility Study.

Published in:

Oncologist, 2010, v. 15, n. 6, p. 636, doi. 10.1634/theoncologist.2009-0265

By:

Jones, Lee W.;
Mourtzakis, Marina;
Peters, Katherine B.;
Friedman, Allan H.;
West, Miranda J.;
Mabe, Stephanie K.;
Kraus, Awilliam E.;
Friedman, Henry S.;
Reardon, David A.

Publication type:

Article

Phase II trial of ponatinib in patients with bevacizumab‐refractory glioblastoma.

Published in:

Cancer Medicine, 2019, v. 8, n. 13, p. 5988, doi. 10.1002/cam4.2505

By:

Lee, Eudocia Q.;
Muzikansky, Alona;
Duda, Dan G.;
Gaffey, Sarah;
Dietrich, Jorg;
Nayak, Lakshmi;
Chukwueke, Ugonma N.;
Beroukhim, Rameen;
Doherty, Lisa;
Laub, Caroline Kane;
LaFrankie, Debra;
Fontana, Brittney;
Stefanik, Jennifer;
Ruland, Sandra;
Caruso, Victoria;
Bruno, Jennifer;
Ligon, Keith;
Reardon, David A.;
Wen, Patrick Y.

Publication type:

Article